Vancouver, British Columbia, Canada, November 10, 2021 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE: APP, FSE: 2FA, OTC Pink: FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, announced CEO Brad Moore will present Citizen Green’s Efixii technology at the CannabiSalud “Business Investment Summit” in Cancun, Mexico, November 18-20, 2021.
The CannabiSalud summit focuses on the commercial and investment opportunities emerging from Mexico’s industrial, medical, and recreational cannabis industry. Topics will include medical, recreational, and industrial market opportunities; legal and regulatory updates; investment and networking opportunities. The conference's objective is to share truthful and legitimate information on the laws and business opportunities in the international cannabis industry, focusing on Mexico; while creating and expanding a network of contacts that includes the most extraordinary personalities in the industry. Mexico is one of the world’s newest and largest legalized medical and recreational cannabis market.
CEO Brad Moore will present Citizen Green Efixii blockchain-based solutions for the medical cannabis industry. He will discuss how Efixii, an unalterable open ledger that records the plant life cycle, increases security, improves product safety, and enhances consumer outcomes in the medical cannabis ecosystem. Blockchain transparency ensures all data is accessible to anyone.
Moore will demonstrate how the SaaS mobile application uses robust Know Your Customer (KYC) identity verification to prevent fraud in compliance with all local regulations. He will also explain how each step in the plant lifecycle is attested and verified with a date, time, and location stamped photo and entered on the ledger.
Product efficacy can be determined using the unique SeedtoSeedTM real-time feedback loop that layers and analyses thousands of individual consumer experiences on a ‘one gram grown, one gram consumed’ basis. Consumers scan an Efixii QR code to view the entire product story. Most importantly, they can review other consumer experiences and make better choices.
Efixii is licensed to cultivators in a SaaS model and is a free-to-use app for cannabis consumers. All cannabis sold through the Portal generates a new sales-commission revenue stream for GCAC. Efixii’s cannabis data is the intellectual property (“IP”) of GCAC. This IP creates an inherent difficulty in replicating or competing with GCAC’s cannabis datasets. GCAC defined their protocols in a provisional U.S. patent application, ‘System of Process and Tracking Cannabis Products and Associated Method Using Blockchain’ filed with the USPTO on Dec. 17, 2020.
GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high quality cannabis datasets that improve patient outcomes and to become the world’s largest cannabis efficacy data provider.
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.